Details for Patent: 6,184,220

✉ Email this page to a colleague

Summary for Patent: 6,184,220

Title:	Oral suspension of pharmaceutical substance
Abstract:	The present invention relates to orally administered suspensions of pharmaceutical active substances of the NSAID type, particularly the antirheumatic agent Meloxicam, which are stabilized by the addition of small amounts of highly dispersed silicon dioxide using high shear forces and adding small amounts of hydrophilic polymers to form a three-dimensional siloid structure, and a process for the preparation thereof.
Inventor(s):	Turck; Dietrich (Ulm, DE), Schmelmer; Veit (Biberach, DE)
Assignee:	Boehringer Ingelheim Pharma KG (Ingelheim, DE)
Application Number:	09/276,208
Patent Claim Types: see list of patent claims	Composition; Formulation;

Drugs Protected by US Patent 6,184,220

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,184,220

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	98105568	Mar 27, 1998

International Family Members for US Patent 6,184,220

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	016196	⤷ Sign Up
Austria	225648	⤷ Sign Up
Australia	3147099	⤷ Sign Up
Australia	762464	⤷ Sign Up
Brazil	9909189	⤷ Sign Up
Canada	2326048	⤷ Sign Up
China	1150888	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.